Word

SANTHERA PHARMACEUTICALS

Status

Dead

Status Code

606

Status Date

Monday, December 9, 2013

Serial Number

77320652

Mark Type

3000

Filing Date

Friday, November 2, 2007

Published for Opposition

Tuesday, December 16, 2008

Abandoned Date

Monday, December 9, 2013

Trademark Owner History

Santhera Pharmaceuticals Holding AG - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular and metabolic system including diabetes, the respiratory system, musculoskeletal and inflammatory disorders, or for use in dermatology, oncology, hematology, ophthalmology, in transplantation; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for the treatment of bone, endocrinological, circulatory, hormonal and rheumatic disorders; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for use in gastro-enterology, for the prevention and treatment of ocular disorders; anti-infectives, anti-bacterials, antivirals, antibiotics, anti-fungals, vaccines, but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for diagnostic purposes, namely, diagnostic preparations for medical purposes; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gebrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; but not for use in the fields of onlcology or rheumatoid arthritis; reagents for medical use; biological preparations for medical purposes but not for use in the fields of onlcology or rheumatoid arthritis; diagnostic agents, preparations and substances for medical purposes

9 Scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, computer hardware and software, for use with medical patient monitoring equipment, for measuring, receiving, processing, transmitting and displaying data; scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, computers, gamma cameras, collimators, aperture plates and computer software, all sold together as a unit for use in measuring the physical and mental condition of individuals affected by ataxia, muscular dystrophies, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use

10 Surgical and medical apparatus and instruments for use in general surgery

16 Printed informational cards in the field of pharmaceuticals; printed publications, namely, newsletters, case studies, and white papers in the fields of pharmaceuticals, central nervous system-related conditions, ophthalmological diseases, and neuromuscular diseases

42 Pharmaceutical research and development services; chemical analysis for the pharmaceutical industry; scientific research and development; scientific research, namely, conducting clinical trials; providing scientific research information in the field of pharmaceuticals and clinical trials

44 Hygienic and beauty care for human beings or animals, namely, providing health, medical and pharmaceutical information, consultancy and advisory services

Color is not claimed as a feature of the mark.
"PHARMACEUTICALS"
The mark consists, in part, of a single line circle with two solid bands extending from the circle, one from the upper left of the circle curving beyond the circle to the left and the second from the bottom right of the circle curving beyond the circle to the right.

Trademark Events

Dec 9, 2013

Abandonment Notice Mailed - No Use Statement Filed

Dec 9, 2013

Abandonment - No Use Statement Filed

Sep 9, 2013

Assigned To Examiner

May 25, 2013

Notice Of Approval Of Extension Request E-Mailed

May 24, 2013

Extension 5 Granted

Apr 29, 2013

Extension 5 Filed

May 24, 2013

Case Assigned To Intent To Use Paralegal

Apr 29, 2013

Teas Extension Received

Oct 31, 2012

Notice Of Approval Of Extension Request E-Mailed

Oct 30, 2012

Extension 4 Granted

Oct 25, 2012

Extension 4 Filed

Oct 25, 2012

Teas Extension Received

May 3, 2012

Notice Of Approval Of Extension Request E-Mailed

May 2, 2012

Extension 3 Granted

Apr 25, 2012

Extension 3 Filed

Apr 25, 2012

Teas Extension Received

Nov 3, 2011

Notice Of Approval Of Extension Request E-Mailed

Nov 2, 2011

Extension 2 Granted

Oct 31, 2011

Extension 2 Filed

Nov 1, 2011

Case Assigned To Intent To Use Paralegal

Oct 31, 2011

Teas Extension Received

Apr 14, 2011

Notice Of Approval Of Extension Request E-Mailed

Apr 12, 2011

Extension 1 Granted

Apr 12, 2011

Extension 1 Filed

Apr 12, 2011

Teas Extension Received

Nov 2, 2010

Noa E-Mailed - Sou Required From Applicant

Sep 17, 2010

Paper Received

Sep 17, 2010

Ttab Release Case To Trademarks

Sep 17, 2010

Opposition Terminated No. 999999

Sep 17, 2010

Opposition Dismissed No. 999999

May 19, 2010

Attorney Revoked And/Or Appointed

May 19, 2010

Teas Revoke/Appoint Attorney Received

May 13, 2010

Paper Received

Apr 27, 2009

Opposition Instituted No. 999999

Dec 19, 2008

Extension Of Time To Oppose Received

Dec 16, 2008

Published For Opposition

Nov 26, 2008

Notice Of Publication

Nov 10, 2008

Law Office Publication Review Completed

Nov 6, 2008

Approved For Pub - Principal Register

Oct 31, 2008

Data Modification Completed

Oct 15, 2008

Previous Allowance Count Withdrawn

Sep 12, 2008

Withdrawn From Pub - Og Review Query

Sep 2, 2008

Law Office Publication Review Completed

Aug 29, 2008

Approved For Pub - Principal Register

Aug 25, 2008

Amendment From Applicant Entered

Aug 25, 2008

Correspondence Received In Law Office

Aug 12, 2008

Paper Received

Feb 19, 2008

Combined Examiner's Amendment/Priority Action Entered

Feb 15, 2008

Assigned To Lie

Feb 15, 2008

Notification Of Examiner's Amendment/Priority Action E-Mailed

Feb 15, 2008

Examiner's Amendment/Priority Action E-Mailed

Feb 15, 2008

Examiners Amendment And/Or Priority Action - Completed

Feb 14, 2008

Assigned To Examiner

Nov 8, 2007

Notice Of Design Search Code Mailed

Nov 7, 2007

New Application Entered In Tram